GlobalData on MSN19h
FDA accepts BMS’ Opdivo-Yervoy combo sBLA for colorectal cancer
The US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence ...
Why Bristol-Myers Squibb Co (BMY) Went Up On Monday?
We recently published a list of 10 Stocks Grow Firmer Despite Mixed Market Sentiment. In this article, we are going to take a ...
Cure Today15h
Neoadjuvant Opdivo Combo Elicits Statistically Significant OS Findings in Resectable NSCLC
Neoadjuvant Opdivo with platinum-doublet chemo had a statistically significant and clinically meaningful improvement versus ...
Investing Snacks1h
Big Money Moves: Bristol-Myers Squibb Gains Investor Confidence
MONECO Advisors LLC significantly increased its holdings in Bristol-Myers Squibb during the fourth quarter, nearly doubling ...